Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?
about
Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?
description
scientific article published on 01 October 2011
@en
name
Pharmacogenetics of oxaliplati ...... ERCC2 good predictive markers?
@en
type
label
Pharmacogenetics of oxaliplati ...... ERCC2 good predictive markers?
@en
prefLabel
Pharmacogenetics of oxaliplati ...... ERCC2 good predictive markers?
@en
P2093
P356
P1476
Pharmacogenetics of oxaliplati ...... ERCC2 good predictive markers?
@en
P2093
Adriaan J C van den Brule
Gesina van Lijnschoten
Harm J T Rutten
Valery E P P Lemmens
P2888
P304
P356
10.1007/BF03256419
P577
2011-10-01T00:00:00Z
P6179
1006209124